Resources*
 |
PROSIGNA PACKAGE INSERT |
 |
Prosigna MSDS |
 |
Prosigna Product Data Sheet |
 |
nCounter® Dx Analysis System User Manual (MAN-C0034) |
| Roche FFPET Kit Package Insert |
1. Go to https://dialog1.roche.com/PI/us/eLabDoc 2. Enter REF number printed on the outside of the Roche kit box 3. Choose the newest version of Method Sheet and download |
- Click here to view publications.
*Veracyte has acquired the Prosigna test. Materials are in transition.
Prosigna is indicated for in vitro diagnostic use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy for assessment of risk of distant recurrence of disease.
